Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Liver Malig nancy is the subject of a report. According to news reporting originating from M annheim, Germany, by NewsRx correspondents, research stated, “Robotic hepatectom y (RH) has been increasingly adopted for the treatment of liver malignancies des pite lacking evidence from randomised trials. We aimed to determine the effect o f RH compared to laparoscopic hepatectomy (LH) on quality of life in patients un dergoing minimally invasive hepatectomy for liver malignancies.” Our news editors obtained a quote from the research from University Hospital Man nheim, “This singleblinded, randomised trial was conducted at a tertiary care a cademic centre (DRKS00027531). Patients with resectable liver malignancies were assessed for eligibility and randomly assigned to either RH or LH with stratific ation by type of malignancy and difficulty of resection. Patients were blinded t o the treatment allocation. The primary outcome was the mean quality of life wit hin 90 days after surgery, measured with the role functioning scale of the Europ ean Organisation for Research and Treatment of Cancer QLQ-C30 questionnaire. Sec ondary outcomes included operating time, morbidity, blood loss, conversion rate, postoperative recovery, and resection margin status. Between February 21, 2022, and Sep 18, 2023, 80 patients (RH: n = 41, LH: n = 39) were included and analys ed on an intention-to-treat basis. Role functioning scores did not differ betwee n RH and LH (mean [SD], 74.3 [23.3] versus 79.6 [22.3] ; mean difference -5.3, 95% CI -15.6 to 5.1, p = 0.547). The compr ehensive complication index was not significantly different between the study gr oups (8.9 [23.1] versus 15.5 [23.9], p = 0.137). There were no differences in other periope rative outcomes.”
NETL
NSTL